← All companies

ATYR

aTyr Pharma, Inc.

ATYR Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$0.49

+0.01 +2.50%

Key statistics

from XBRL data in SEC filings

Market cap

$48.2M

Revenue (TTM)

$190K

Net income (TTM)

-$70.0M

EPS (TTM)

$-0.74

P/E ratio

—

Dividend yield

—

Free cash flow

-$62.1M

Cash

$10.0M

Total assets

$79.7M

Gross margin

—

52-week range

$0.40 – $6.50

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Terminated a material agreement Jul 31, 2026 8-K Delisting notice or listing-rule failure Jun 8, 2026 8-K Regulation FD disclosure Jun 1, 2026 10-Q Quarter ended 2026-03-31 May 15, 2026 8-K Results of operations (earnings release) May 15, 2026 8-K Results of operations (earnings release); Regulation FD disclosure; Other events May 11, 2026 10-K Fiscal year ended 2025-12-31 Mar 5, 2026 8-K Results of operations (earnings release) Mar 5, 2026 8-K Delisting notice or listing-rule failure Dec 5, 2025 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 6, 2025 8-K Other events Sep 15, 2025 8-K/A Results of operations (earnings release) Aug 8, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Material impairment Aug 7, 2025 10-Q Quarter ended 2025-03-31 May 7, 2025 8-K Results of operations (earnings release) May 7, 2025 8-K Director or officer change; Shareholder vote results May 6, 2025 10-K Fiscal year ended 2024-12-31 Mar 13, 2025 8-K Results of operations (earnings release) Mar 13, 2025 8-K Entered a material agreement Dec 23, 2024 8-K Director or officer change Dec 12, 2024 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release) Nov 7, 2024 10-Q Quarter ended 2024-06-30 Aug 13, 2024 8-K Results of operations (earnings release) Aug 13, 2024 8-K Other events Jul 22, 2024 8-K Director or officer change; Item 5.05; Shareholder vote results; Other events May 29, 2024 10-Q Quarter ended 2024-03-31 May 2, 2024 8-K Results of operations (earnings release) May 2, 2024 10-K Fiscal year ended 2023-12-31 Mar 14, 2024 8-K Results of operations (earnings release) Mar 14, 2024 10-Q Quarter ended 2023-09-30 Nov 9, 2023 8-K Results of operations (earnings release) Nov 9, 2023 8-K Regulation FD disclosure; Other events Sep 26, 2023 8-K Other events Sep 11, 2023 10-Q Quarter ended 2023-06-30 Aug 9, 2023 8-K Results of operations (earnings release) Aug 9, 2023 8-K Director or officer change; Amended charter or bylaws; Item 5.05; Shareholder vote results May 19, 2023 10-Q Quarter ended 2023-03-31 May 9, 2023